Patent · US Active

Compounds

US8853420B2 · kind B2 · utility

0Cited by

6References

15Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Matthias Treu · Wien, AT
Thomas Karner · Wien, AT
Ulrich Reiser · Wien, AT

Key dates

Filing date	Jul 28, 2009
Grant date	Oct 7, 2014
Priority date	—
Expiry date	Feb 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1), wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.